41
Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects
Condition(s): Aspergillosis; Invasive Pulmonary Aspergillosis; Neuroaspergillosis Last Updated: May 10, 2012Withdrawn
19232 Clinical Trials for: Therapy, Combination, Page 3 of 962
Hide Studies Not Seeking New Volunteers
42
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Condition(s): Chronic Hepatitis C Infection Last Updated: March 1, 2013Active, not recruiting
43
A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
Condition(s): HIV Infections Last Updated: April 2, 2012Completed
44
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Condition(s): Brain Metastases From Solid Tumors Last Updated: October 11, 2012Active, not recruiting
45
Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Condition(s): Chronic Hepatitis C Last Updated: January 6, 2011Not yet recruiting
46
A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma
Condition(s): Melanoma Last Updated: April 25, 2013Active, not recruiting
47
Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
Condition(s): Thyroid Cancer Last Updated: April 19, 2013Active, not recruiting
48
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
Condition(s): Diabetes Last Updated: January 17, 2013Recruiting
49
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Condition(s): Hepatitis C, Chronic Last Updated: March 7, 2013Active, not recruiting
50
Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma
Condition(s): Asthma Last Updated: March 25, 2013Active, not recruiting
51
Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)
Condition(s): Chronic Hepatitis C Virus Last Updated: May 8, 2013Recruiting
52
Treatment of Hypertension With Adalat® in Combination With Other Drugs
Condition(s): Hypertension Last Updated: June 26, 2012Completed
53
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
Condition(s): HIV Infections Last Updated: March 30, 2012Completed
54
E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)
Condition(s): Advanced Solid Tumors Last Updated: May 10, 2013Recruiting
55
Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
Condition(s): Hypercholesterolemia; Chronic Nephropathy Last Updated: April 27, 2009Active, not recruiting
56
EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
Condition(s): Multiple Sclerosis Last Updated: June 22, 2009Completed
57
Gemcitabine in Combination With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Condition(s): Resectable Pancreatic Adenocarcinoma Last Updated: May 3, 2013Active, not recruiting
58
A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C
Condition(s): Hepatitis C, Chronic Last Updated: May 7, 2013Recruiting
59
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
Condition(s): HBe Negative Chronic Hepatitis B; Hepatitis B Viral Infection Last Updated: May 7, 2009Terminated
60
Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana
Condition(s): Malaria; Schistosomiasis; Helminthiasis; Anemia; Change in Sustained Attention Last Updated: October 22, 2011Recruiting
